GENE ONLINE|News &
Opinion
Blog

Fujie Tham

WRITTEN BY Fujie Tham

FDA Approves Alnylam’s Rare Disease RNAi Therapeutic
2022-06-15
Canada Approves Amylyx’s Experimental ALS Drug
2022-06-14
Massive Human CRISPR-Based Genotype-Phenotype Map Is Now Complete
2022-06-13
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
Over 50 Taiwan Organizations to Present at 2022 BIO International Convention
2022-06-08
EQT and Mubadala to Acquire Envirotainer in $3 Billion Deal
2022-06-08
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
Everest and Gilead Announce Positive Phase 3 Results of Breast Cancer Drug
2022-06-06
Astellas’ $20.5M Deal With GO Therapeutics to Develop Immuno-Oncology Therapeutics
2022-06-02
First Oral SMA Drug by Roche Now Available to Newborns
2022-06-01
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
Vaccines Against Cancers May Be the Future
2022-05-30
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
1 2 3 4 5
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top